10-K
File 001-40064
ANNUAL REPORT
- Filing date
- 26 Mar 2024
- Reporting date
- 31 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
Virpax Pharmaceuticals, Inc. reports
- Company location
- Berwyn, PA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
Virpax Pharmaceuticals, Inc. has filed 278 SEC EDGAR filings since 05 Apr 2018
SEC filing history
Showing 101-125 of 278 matching filings.
Per page
25
Current page
5
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 26 Mar 2024
- Reporting date
- 26 Mar 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 18 Mar 2024
- Reporting date
- 15 Mar 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 01 Mar 2024
- Reporting date
- 29 Feb 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 31 Jan 2024
- Reporting date
- 29 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13G/A
File 005-92861
VRPX 13GA 1.04.24
- Filing date
- 02 Jan 2024
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 29 Dec 2023
- Reporting date
- 28 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 13 Dec 2023
- Reporting date
- 08 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
DEF 14A
File 001-40064
PROXY STATEMENT
- Filing date
- 07 Dec 2023
- Reporting date
- 28 Dec 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 07 Dec 2023
- Reporting date
- 06 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-Q
File 001-40064
QUARTERLY REPORT
- Filing date
- 07 Dec 2023
- Reporting date
- 30 Sep 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
PRE 14A
File 001-40064
PRER14A1123_VIRPAXPHARMA
- Filing date
- 21 Nov 2023
- Reporting date
- 21 Nov 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 17 Nov 2023
- Reporting date
- 16 Nov 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 17 Nov 2023
- Reporting date
- 15 Nov 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 16 Nov 2023
- Reporting date
- 15 Nov 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
NT 10-Q
File 001-40064
NOTIFICATION OF LATE FILING
- Filing date
- 15 Nov 2023
- Reporting date
- 30 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
8-K
File 001-40064
CURRENT REPORT
- Filing date
- 11 Oct 2023
- Reporting date
- 10 Oct 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing